1. Perioperative Cefazolin Prophylaxis in Pediatric Cardiac Surgery: A Prospective, Cohort Study
- Author
-
Jessica Suna, Gregory Moloney, Supreet P. Marathe, Benjamin Bierbach, Jason A. Roberts, Suzanne Parker, Jacobus P.J. Ungerer, Brett McWhinney, Tavey Dorofaeff, Prem Venugopal, and Nelson Alphonso
- Subjects
Cohort Studies ,Pulmonary and Respiratory Medicine ,Cardiopulmonary Bypass ,Cefazolin ,Humans ,Surgical Wound Infection ,Surgery ,Prospective Studies ,Antibiotic Prophylaxis ,Cardiac Surgical Procedures ,Child ,Cardiology and Cardiovascular Medicine ,Anti-Bacterial Agents - Abstract
This study's objective was to determine the effect of age, prolonged bypass, and hypothermia on serum cefazolin concentrations in children undergoing cardiac surgery.A prospective, single-center, observational study was conducted, examining children undergoing cardiac surgery. Participants received cefazolin intravenously approximately 1 hour before skin incision, 3 hourly intraoperatively, and 8 hourly postoperatively. Blood samples were collected at 6 to 8 time points intraoperatively and at 6 time points in the first 24 hours postoperatively. Target unbound serum cefazolin concentrations were 2 mg/L.Sixty-eight patients were enrolled in the study, and 64 were included in the analysis. All maintained concentrations ≥ 2 mg/L throughout the operation. Nineteen patients (30%) did not maintain concentrations ≥ 2 mg/L in the first 24 hours after surgery. Older, larger children (P.0001) were significantly less likely to achieve target unbound serum cefazolin concentrations.Intraoperative cefazolin concentrations reached the target concentration in all pediatric cardiac surgical cases. Postoperative cefazolin dosing appears to be insufficient to achieve minimum inhibitory concentrations in many patients.
- Published
- 2022